Comparison of First-Line Treatments for Patients With Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-analysis

IMPORTANCE: Combinations of chemotherapy with immunotherapy or bevacizumab in first-line treatments of extensive-stage small cell lung cancer (ES-SCLC) have been evaluated in various clinical trials. However, it remains unclear what the optimal combination regimen is. OBJECTIVE: To clarify which fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ting, Zhang, Zhonghan, Luo, Fan, Zhao, Yuanyuan, Hou, Xue, Liu, Tingting, Wang, Kai, Zhao, Hongyun, Huang, Yan, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573680/
https://www.ncbi.nlm.nih.gov/pubmed/33074323
http://dx.doi.org/10.1001/jamanetworkopen.2020.15748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573680/
https://www.ncbi.nlm.nih.gov/pubmed/33074323
http://dx.doi.org/10.1001/jamanetworkopen.2020.15748

Ejemplares similares